360 Results (Page 1 of 15)
India Markets Research Reports
India Infectious Disease Drugs Market Analysis
This report presents a strategic analysis of the India Infectious Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India Infectious Disease Drugs Market, offering unmatched value, accuracy and expert insights.
India Ambulance Service Market Analysis
India Ambulance Service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Ambulance Service is expanding as a result of rising incidence of traumatic accidents and medical tourism in both developed and developing nations. This demand is fueling the development of better infrastructure and services for timely diagnosis and treatment while transportation of patient from one place to healthcare facilities. Some of the key players in the global Ambulance Service Market include Babcock International Group PLC, Acadian Ambulance Service, BVG India Limited, America Ambulance Service, Inc., Falck A/S, Air Methods Corporation, Ziqitza Health Care Limited, Harmonie Ambulance, Envision Healthcare, and Medivic Aviation.
India Cancer Immunotherapy Market Analysis
India's cancer immunotherapy market is expected to witness growth from $2.04 Bn in 2022 to $4.41 Bn in 2030 with a CAGR of 10.1% for the forecasted year 2022-2030. Supportive government policies for promoting cancer care and the growing acceptance of cancer immunotherapy in India are responsible for the growth of the market. The Indian cancer immunotherapy market is segmented by type, application, and end user. Swisschem Healthcare, Epigeneres Biotech, and Bayer are the major players in the Indian cancer immunotherapy market.
India Artificial Intelligence (AI) in Diagnostics Market Analysis
India's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $0.02 Bn in 2022 to $0.24 Bn by 2030, registering a CAGR of 38% during the forecast period of 2022-2030. The market will be driven by the rising number of startups in AI diagnostic technology and government initiatives. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Qure AI.
India Antiviral Drugs Market Analysis
This report presents a strategic analysis of the India Antiviral Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India Antiviral Drugs Market, offering unmatched value, accuracy and expert insights.
India Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Analysis
India's Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics market is expected to grow from $67 Mn in 2022 to $181 Mn in 2030 with a CAGR of 13.20% for the year 2022-30. PNH is becoming more common in India, which is anticipated to increase demand for PNH therapies there. The demand for PNH treatments is anticipated to rise as PNH awareness rises in India and more people are likely to seek diagnosis and treatment for the condition. The market is segmented by therapy, diagnostic test, by distribution channels. Some key players in this market include Sun Pharmaceutical, Cipla, Lupin, Aurobindo Pharma, Zydus Cadila Healthcare, Amgen, CSL Behring and Bioverativ.
India Cardiac Monitoring Devices Market Analysis
This report presents a strategic analysis of the India Cardiac Monitoring Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India Cardiac Monitoring Devices Market, offering unmatched value, accuracy and expert insights.
India Teleradiology Market Analysis
India's teleradiology market size was valued at $43 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 14.7% from 2022 to 2030, reaching $129 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The Indian teleradiology market will grow due to the Increasing demand for remote radiology services. The key market players are Teleradiology Solutions, Radispark Healthcare, Medica Group of Hospitals, Medray Imaging Pvt. Ltd., Medsynaptic Pvt Ltd, Global Diagnostics, Aarna Healthcare, and others.
India Cardiovascular Diseases Therapeutics Market Analysis
India's cardiovascular disease therapeutics market is projected to grow from $2.95 Bn in 2022 to $6.44 Bn in 2030 with a CAGR of 10.22% for the year 2022-2030. The changing lifestyles leading to the increased prevalence of hypertension and other cardiovascular diseases are the major market drivers. The India cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Aventis Pharma, Viridis Biopharma, and Bayer are the major players in the India cardiovascular disease therapeutics market.
India Dental Caries Detectors Market Analysis
The India Dental Caries Detectors Market was valued at $4.2 Mn in 2023 and is predicted to grow at a CAGR of 11.9% from 2023 to 2030, to $9.1 Mn by 2030. India Dental Caries Detectors Market is growing due to High prevalence of dental caries, Growing awareness, Government Initiatives and Funding, and Advancements in Technology. The market is primarily dominated by players such as Coltene Group, Shofu Dental Corporation, Air Techniques Inc, KaVo Dental, GmbH Quantum Dental Technologies, Sirona Dental Systems, Dentsply Sirona.
India Clinical Nutrition for Diabetes Care Market Analysis
The India Clinical Nutrition for Diabetes Care Market was valued at $39.10 Mn in 2023 and is predicted to grow at a CAGR of 7.78% from 2023 to 2030, to $66.06 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Amway India, Pfizer Inc., and Zoic Pharmaceuticals among others.
India Pharmacy Automation Device Market Analysis
The India Pharmacy Automation Device Market was valued at $100 Mn in 2023 and is predicted to grow at a CAGR of 12.9% from 2023 to 2030, to $233.9 Mn by 2030. India Pharmacy Automation Device Market is growing due to Increasing Healthcare Expenditure, Rising Chronic Disease Burden, Cost Containment and Efficiency. The market is primarily dominated by players such as Cotmac Electronics Pvt Ltd, Zifo Technologies, Becton Dickinson and Company, Omron Healthcare Co Ltd, Capsa Solutions, LLC, Pearson Medical Technologies LLC, Cotmac Electronics Pvt Ltd, Baxter; Talyst, LLC.
India Cardiac Pacemakers Market Analysis
The India Cardiac Pacemakers Market was valued at $73.60 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $112.13 Mn by 2030. The key drivers of this industry include medical tourism, rising prevalence, and government initiatives. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
India Von Willebrand Disease Therapeutics Market Analysis
India Von Willebrand Disease Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Some of the key factors influencing market growth include the introduction of new von Willebrand disease therapies, rising awareness of the condition due to an increase in government initiatives and awareness campaigns, and expanding partnerships and collaborations between top research institutions and regulatory bodies. Major global players in Von Willebrand Disease Therapeutics Market are Octapharma AG Grifols, S.A. Shire plc Bayer AG CSL Behring Pfizer, Inc. Akorn, Inc. Ferring B.V.
India Leukocyte Adhesion Deficiency (LAD-I) Market Analysis
India Leukocyte Adhesion Deficiency (LAD-I) therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. An uncommon genetic condition called leukocyte adhesion deficiency (LAD-I) impairs the immune system's capacity to combat infections. There is currently no cure for LAD-I, and there are few effective treatments available. To fill this unmet medical need, new medicines are becoming more and more popular. Vertex Pharmaceuticals, Orpha Labs, Avalo Therapeutics, Inc., Rocket Pharmaceuticals, Inc., Aspen Neuroscience, Magenta Therapeutics, Rubius Therapeutics, Enochian Biosciences, Sana Biotechnology, and Sigma-Aldrich are major global players.
India Guillain-Barre Syndrome (GBS) Drugs Market Analysis
India Guillain-Barre Syndrome (GBS) drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Guillain-Barre Syndrome (GBS) drugs is growing rapidly as a result of increase in the incidence and prevalence of the guillain-barre syndrome, advancements in technology and development in healthcare, support and funding by governments globally, rise in the geriatric population and increase in the prevalence of chikungunya and immune diseases like multiple sclerosis , increase in the approvals of immunoglobulins by regulatory bodies and increase in research and development activities by pharmaceutical companies. Alexion Pharmaceuticals Inc., Annexon Inc., Cellenkos Inc., Cresence AS, Akari Therapeutics Plc, Chugai Pharmaceutical Co Ltd are the key market players operating in global gullian barre syndrome drugs market.
India Fibrodysplasia Ossificans Progressiva Drugs Market Analysis
India Fibrodysplasia Ossificans Progressiva Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The market for Fibrodysplasia Ossificans Progressiva Drugs is expanding as a result of growing incidence and prevalence of fibrodysplasia ossificans progressiva , increase in the number of R&D activities, increase in Partnerships and Collaborations between market players. Pfizer Inc., AstraZeneca, Limited, Regeneron Pharmaceuticals, Inc, Clementia Pharmaceuticals, Novartis are the top key market players operating in the global Fibrodysplasia Ossificans Progressiva Drugs market.
India Duchenne Muscular Dystrophy (DMD) Drugs Market Analysis
India Cystic Fibrosis Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Duchenne Muscular Dystrophy (DMD) Drugs is expanding as a result of rising incidence and prevalence of duchenne muscular dystrophy, improved diagnosis of the disease, emergence of mutation specific and gene specific therapies, favourable government initiatives and supportive regulatory environments in various countries. Sarepta therapeutics, PTC therapeutics, Santhera pharmaceuticals are the top key market players operating in the Cystic fibrosis drugs market.
India Clinical Nutrition for Cancer Care Market Analysis
The India Clinical Nutrition for Cancer Care Market was valued at $102.4 Mn in 2023 and is predicted to grow at a CAGR of 8.04% from 2023 to 2030, to $175.9 Mn by 2030. The key drivers of the market include the growing cancer burden, increasing risk of malnutrition in oncology patients, and advancements in nutritional products. The prominent players of the India Clinical Nutrition for Cancer Care Market are Reckitt Benckiser, Nestlé Health Science, Abbott Nutrition, B. Braun Melsungen AG, and Fresenius Kabi, among others.
India Home Infusion Therapy Market
The India Home Infusion Therapy Market was valued at $654 Mn in 2023 and is predicted to grow at a CAGR of 11.1% from 2023 to 2030, to $1366.3 Mn by 2030. The key drivers of the market include low cost, rising prevalence of chronic diseases, and expanding geriatric population. The prominent players of the India Home Infusion Therapy Market are Poly Medicure, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
India Complex Regional Pain Syndrome (CRPS) Market Analysis
India Complex regional pain syndrome (CRPS) Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Complex regional pain syndrome (CRPS) is expanding as a result of rising incidence of complex regional pain syndrome and the growing number of patients suffering from chronic pain and failing back syndrome. Growth in R&D spending by both commercial and public institutions, as well as favourable government legislation and increase in product launches are other factors increasing market growth. Ovid therapeutics, Astra Zeneca, Abbott, GSK, Viatris and Johnson & Johnson Services are the top key market players in Global Complex regional pain syndrome (CRPS) market.
India Autoimmune Hemolytic Anemia Drugs Market Analysis
India Autoimmune Hemolytic Anemia Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. A rise in the prevalence of certain autoimmune illnesses and malignancies, as well as increased funding for research into innovative interventions and growing demand for novel therapies, are all contributing to an increase in the market for medications to treat autoimmune hemolytic anaemia. Major global players in Autoimmune Hemolytic Anemia Drugs Market are F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd, Zydus Cadila, Vertice Pharma, Concord Biotech, Alkem Labs, Dr. Reddy's Laboratories Ltd, Jubilant Life Sciences Ltd, Strides Pharma Science Limited, Mylan N.V., Novartis AG, Sanofi, Rigel Pharmaceuticals Inc, Incyte Corporation, Alexion Pharmaceuticals, Apellis Pharmaceuticals.
India ADPKD (Autosomal dominant polycystic kidney disease) Drugs Market Analysis
India ADPKD (Autosomal dominant polycystic kidney disease) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. The market for drugs to treat polycystic kidney disease is driven by an increase in patients who require dialysis or renal failure. A significant factor influencing the growth rate of the polycystic kidney disease (PKD) drugs market is the rise in healthcare spending, which helps to improve its infrastructure. Major global players in ADPKD (Autosomal dominant polycystic kidney disease) Drugs Market are Otsuka Pharmaceutical Co., Ltd., Regulus Therapeutics, Palladio Biosciences, Reata Pharmaceuticals, Inc., Galapagos NV, AceLink Therapeutics, Inc., Exelixis, Inc, XORTX Therapeutics Inc., Sanofi S.A., PanoTherapeutics, Inc.
India Cystic Fibrosis (CF) Therapeutics Market Analysis
India Cystic Fibrosis (CF) Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Cystic fibrosis (abbreviated CF) is a genetic disorder that causes mucus to build up in certain organs of the body, particularly the lungs and pancreas, resulting in breathing problems, respiratory infections and faulty digestion. The increasing prevalence of Cystic Fibrosis (CF) coupled with the rising treatment rate is one of the key factors anticipated to propel the demand for cystic fibrosis therapeutics over the forecast period. The key players are consistently involved in the development of new or combination of products to treat cystic fibrosis. Investment in the R&D is one of the strategic measures to beat the competition. The key players in this market are AbbVie Inc.; F. Hoffmann-La Roche Ltd; Gilead; Novartis AG; Vertex Pharmaceuticals Inc.; AIT (Advanced Inhalation Therapies); Alaxia; Teva Pharmaceutical Industries Ltd; Merck & Co. Inc.; Alcresta Therapeutics Inc.; Allergan; and AstraZeneca.
India Hereditary Angioedema Therapeutics Market Analysis
India Hereditary Angioedema Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. A uncommon genetic condition known as hereditary angioedema (HAE) is characterised by recurrent episodes of swelling in different body areas. It is brought on by a lack or malfunction of certain proteins involved in controlling the immune response. The regulatory authorities have designated numerous HAE therapies as orphan drugs as a result of this classification, pharmaceutical companies are given some incentives including financial advantages and prolonged exclusivity, which may promote investment in HAE R&D. The increasing prevalence and diagnosis of HAE around the world have been driving the growth of the global market for HAE therapies. This trend offers pharmaceutical businesses the chance to increase their market share, make research and development investments, and introduce novel treatments to various geographic areas. Hereditary angioedema therapies are being developed and produced by a number of international pharmaceutical companies (HAE). Takeda Pharmaceutical Company Limited, Inc., CSL Behring, Pharming Group NV, Ionis Pharmaceuticals, Pharvaris, Dyax Corp., Shire (now a part of Takeda), Attune Pharmaceuticals, Prometic Life Sciences Inc., KalVista Pharmaceuticals, and Biocryst are some of these organisations.
